Document is current

Any future updates will be listed below

Correction: Predicting progression-free survival using dynamic contrast-enhanced imaging-based radiomics in advanced nasopharyngeal carcinoma patients treated with nimotuzumab

Crossref DOI link: https://doi.org/10.1007/s00330-025-11530-3

Published Online: 2025-04-14

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark